Skip to content
MarketScale
‹ Back to IndustriesHealthcare

FOOTInnovate Webinar Recap: Application of Weightbearing CT (WBCT) in Common Foot & Ankle Disorders

Applications of Weight Bearing CT in Common Foot & Ankle Disorders (Click here to access webinar) Presented by Dr. Daniel J. Cuttica, DO Key Points The optimal workflow for in-office Weight Bearing CT (WBCT) imaging is to get insurance authorization, perform the scan, and review scan results all during the initial patient appointment. Hallux valgus is…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Applications of Weight Bearing CT in Common Foot & Ankle Disorders (Click here to access webinar)
Presented by Dr. Daniel J. Cuttica, DO

Key Points

  • The optimal workflow for in-office Weight Bearing CT (WBCT) imaging is to get insurance authorization, perform the scan, and review scan results all during the initial patient appointment.
  • Hallux valgus is a tri-plane deformity, and weight bearing allows for a better understanding of coronal plane rotation.
  • Post-operatively, weight bearing CT can provide a precise view of the rate of fusion healing.

The webcast covered the importance of weight bearing in foot and ankle imaging, the applications of weight bearing CT in common foot and ankle disorders, and how it can be incorporated effortlessly into practices.

According to Dr. Cuttica, “Weight bearing is the functional position of the foot. It allows for us to better determine alignment, to form an assessment of the foot, and to formulate treatment plans. So, weightbearing, obviously as we all know, is very, very important.”

A surgeon at Orthopaedic Foot & Ankle Center (OFAC) in Falls Church, Virginia, Dr. Daniel J. Cuttica, DO, boasts a number of specialties and interests, including foot and ankle surgery, reconstructive surgery, sports-related foot and ankle disorders, cartilage disorders, total ankle replacement, diabetic limb salvage, and dance medicine.

Background

Dr. Cuttica states, “When you evaluate a patient, in addition to clinical exam, you know that imaging is going to be very valuable in diagnosing, treating, and assessing outcomes in foot and ankle.”

However, with weight bearing imaging, you can more reliably identify pathology such as subtle arch collapse, loss of cartilage/joint space, degenerative changes, and impingement.

The Limitations of Conventional CT vs. the Benefits of WBCT

 When compared to plain X-Rays, “Computed Tomography (CT) can be very, very beneficial for bone and joint problems, and it does give us a large amount of additional information.” However, Dr. Cuttica explains, “The biggest limitation, at least in foot and ankle, with CT again, is probably your inability to obtain weight bearing images.”

The benefits of CBCTs include:

  • Easy to operate
  • Shorter scan time
  • Patient safety
  • Optimal patient positioning
  • Offloads capacity
  • Flexible siting/easy relocation

There are also many advantages to using WBCT, including:

  • Ability to obtain weight bearing images
  • High contrast and spatial resolution
  • Fast image acquisition time
  • Decreased radiation (typically 0.01-0.03 mSv vs. 0.07 mSv for Conventional CT)
  • Relatively small scanner size with portability
  • Less capitalization cost than Conventional CT

Implementing In-Office WBCT for Foot & Ankle

 According to Dr. Cuttica, because of its low radiation dosage and small size, CBCT is ideal for an office setting. For patients, a WBCT scanner in the office is more convenient, can help to avoid unnecessary follow up appointments, and allows for immediate feedback of their diagnosis. For physicians, an in-office WBCT is also more convenient, enabling quicker treatment plan formulation, helping to avoid overbooking, while allowing for more rapid surgery scheduling.

Dr. Cuttica reviewed three office workflow options for in-office WBCT imaging:

  • Option A – Scan and have patient follow up to go over scans at a later date (not the most efficient)
  • Option B – Get insurance authorization and perform the scan at the next visit before the patient is seen
  • Option C – Get insurance authorization, perform the scan, and go over scans at initial appointment (most efficient and most convenient for patients)

Further, WBCT images can be conveniently emailed or uploaded to another doctor or radiologist.

Dr. Cuttica said the most common and beneficial WBCT foot and ankle applications include:

  • Hallux valgus
  • Pes planovalgus
  • Midfoot/Lis Franc injury
  • Ankle fracture/syndesmosis
  • Deformity/Charcot
  • OCD
  • Bone healing

 In Hallux Valgus, WBCT Scans Accentuate Deformities & Guide Treatment

(17:03) In hallux valgus—a triplane deformity—it’s necessary to understand all the components of the malformation. Dr. Cuttica pointed out that WBCT allows for better understanding of coronal plane rotation. As you can see in the image below (17:40), the WBCT imaging clearly shows the first metatarsal joint architecture, the sesamoid position, if there is any flattening/erosion of the crista, as well as a first metatarsal rotation, all of which need to be taken into account when treating bunion deformity.

This screen capture from Dr. Cuttica’s FOOTInnovate webinar displays rotation of the first metatarsal.

(18:16) Dr. Cuttica displayed a typical case of a 47-year-old female with bunion pain who, upon both exam and radiographically, had a hypermobile first ray with some inter-gapping at her first tarsal-metatarsal joint, as well as a moderately sized bunion. (19:43) When Dr. Cuttica performed a WBCT, the rotation of her first metatarsal was visible. Due to the patient’s instability and hypermobility at the joint, Cuttica’s team treated her with the Lapidus procedure—correcting her IM angle and coronal frontal plane rotation—as well as an Akin osteotomy.

(19:55) At the 6-week post-op exam, the patient’s foot looked fairly healed, and allowed the patient to progress with some activity. (20:19) At the 12-week exam, however, an additional WBCT allowed Dr. Cuttica to better assess the sesamoid position and evaluate the fusion. The sesamoids looked reduced, but it was also revealed that the patient was not fully fused.

https://www.curvebeam.com/blog/wp-content/uploads/2019/11/sesamoids-post-hallux-valgus-reduced.jpg

This screen capture from Dr. Cuttica’s FOOTInnovate webinar shows the sesamoid position has improved post-operatively.

https://www.curvebeam.com/blog/wp-content/uploads/2019/11/lapidus-post-op-non-fusion.jpg

However, this screen capture from Dr. Cuttica’s webinar revealed the patient’s bones had not fully fused after undergoing a lapidus procedure.

These comprehensive views enabled Dr. Cuttica to better progress with the patient’s treatment—in this case, limiting the patient’s activities as she had a bit more healing to go.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512